Civic Intelligence

The Leukemia & Lymphoma Societyinc Inc

EIN 13-5644916 • 501(c)3 • Washington, DC

View Organization Page

Profile

Our mission is to cure leukemia, lymphoma, hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

1201 15th Street NW Suite 410Washington, DC 20005

www.lls.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

53rd percentile

0.32x

Higher debt load relative to assets than 53% of similar nonprofits.

501(c)3 • $250M-$1B nonprofits • Source year 2025

Liabilities / Revenue

50th percentile

0.48x

Higher debt load relative to revenue than 50% of similar nonprofits.

501(c)3 • $250M-$1B nonprofits • Source year 2025

Net Margin

13th percentile

-11%

Higher net margin than 13% of similar nonprofits.

501(c)3 • $250M-$1B nonprofits • Source year 2025

Top Officer Pay

54th percentile

$930,517

Higher top officer pay than 54% of similar nonprofits.

Top officer pay equals 0.3% of source-year revenue.

501(c)3 • $250M-$1B nonprofits • Source year 2025

Asset Growth

6th percentile

-12%

Faster asset growth than 6% of similar nonprofits.

501(c)3 • $250M-$1B nonprofits • Annualized from 2024 to 2025

Revenue Growth

17th percentile

-2.6%

Faster revenue growth than 17% of similar nonprofits.

501(c)3 • $250M-$1B nonprofits • Annualized from 2024 to 2025

Balance Sheet
Liabilities / Assets53rd percentile

Assets

Down

$532,209,663

Down $69,800,856 (-12%) from 2024

Liabilities

Down

$171,712,720

Down $39,345,618 (-19%) from 2024

Net Assets

Down

$360,496,943

Down $30,455,238 (-7.8%) from 2024

Operations
Liabilities / Revenue50th percentileNet Margin13th percentile

Revenue

Down

$358,698,504

Down $9,543,555 (-2.6%) from 2024

Expenses

Up

$398,128,476

Up $26,336,304 (+7.1%) from 2024

Net Income

Down

-$39,429,972

Down $35,879,859 (-1011%) from 2024

Trend Graphs

Balance Sheet Trend

Asset Growth6th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$800M$600M$400M$200M$0Assets 2010: $221,660,340Liabilities 2010: $112,213,271Net Assets 2010: $109,447,0692010Assets 2011: $224,271,874Liabilities 2011: $104,487,981Net Assets 2011: $119,783,8932011Assets 2012: $223,445,924Liabilities 2012: $109,397,145Net Assets 2012: $114,048,7792012Assets 2013: $236,325,556Liabilities 2013: $135,316,123Net Assets 2013: $101,009,4332013Assets 2014: $242,581,527Liabilities 2014: $145,444,419Net Assets 2014: $97,137,1082014Assets 2015: $214,485,806Liabilities 2015: $116,963,860Net Assets 2015: $97,521,9462015Assets 2016: $217,192,867Liabilities 2016: $99,112,566Net Assets 2016: $118,080,3012016Assets 2017: $272,265,949Liabilities 2017: $119,978,224Net Assets 2017: $152,287,7252017Assets 2018: $382,344,839Liabilities 2018: $146,112,465Net Assets 2018: $236,232,3742018Assets 2019: $454,102,204Liabilities 2019: $185,710,815Net Assets 2019: $268,391,3892019Assets 2020: $581,677,610Liabilities 2020: $215,555,172Net Assets 2020: $366,122,4382020Assets 2021: $743,613,782Liabilities 2021: $229,841,284Net Assets 2021: $513,772,4982021Assets 2022: $693,676,206Liabilities 2022: $321,732,744Net Assets 2022: $371,943,4622022Assets 2023: $643,891,871Liabilities 2023: $271,338,303Net Assets 2023: $372,553,5682023Assets 2024: $602,010,519Liabilities 2024: $211,058,338Net Assets 2024: $390,952,1812024Assets 2025: $532,209,663Liabilities 2025: $171,712,720Net Assets 2025: $360,496,9432025

Highlighted filing

2025

Assets$532,209,663
Liabilities$171,712,720
Net Assets$360,496,943
Open 2025 Filing

Operations Trend

Revenue Growth17th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$600M$400M$200M$0-$200MExpenses 2010: $250,482,3412010Expenses 2011: $280,841,1242011Expenses 2012: $292,394,5142012Expenses 2013: $306,978,6652013Revenue 2014: $310,095,987Expenses 2014: $317,198,282Net Income 2014: -$7,102,2952014Revenue 2015: $281,628,930Expenses 2015: $277,443,057Net Income 2015: $4,185,8732015Revenue 2016: $271,727,274Expenses 2016: $254,769,311Net Income 2016: $16,957,9632016Revenue 2017: $345,298,600Expenses 2017: $315,486,013Net Income 2017: $29,812,5872017Revenue 2018: $438,854,761Expenses 2018: $356,450,352Net Income 2018: $82,404,4092018Revenue 2019: $396,221,152Expenses 2019: $367,321,473Net Income 2019: $28,899,6792019Revenue 2020: $496,221,309Expenses 2020: $393,996,450Net Income 2020: $102,224,8592020Revenue 2021: $477,663,716Expenses 2021: $359,848,179Net Income 2021: $117,815,5372021Revenue 2022: $426,997,204Expenses 2022: $518,622,394Net Income 2022: -$91,625,1902022Revenue 2023: $378,338,490Expenses 2023: $386,072,968Net Income 2023: -$7,734,4782023Revenue 2024: $368,242,059Expenses 2024: $371,792,172Net Income 2024: -$3,550,1132024Revenue 2025: $358,698,504Expenses 2025: $398,128,476Net Income 2025: -$39,429,9722025

Highlighted filing

2025

Revenue$358,698,504
Expenses$398,128,476
Net Income-$39,429,972
Open 2025 Filing

Filings

Most recent year

2025 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$532,209,663
Liabilities
$171,712,720
Net assets
$360,496,943
Revenue
$358,698,504
Expenses
$398,128,476
Net income
-$39,429,972
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$532$172$360$359$398$39.4
2024Detailed filing. Detailed filing data is available for this year.$602$211$391$368$372$3.55
2023Detailed filing. Detailed filing data is available for this year.$644$271$373$378$386$7.73
2022Detailed filing. Detailed filing data is available for this year.$694$322$372$427$519$91.6
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$744$230$514$478$360$118
2020Detailed filing. Detailed filing data is available for this year.$582$216$366$496$394$102
2019Detailed filing. Detailed filing data is available for this year.$454$186$268$396$367$28.9
2018Detailed filing. Detailed filing data is available for this year.$382$146$236$439$356$82.4
2017Detailed filing. Detailed filing data is available for this year.$272$120$152$345$315$29.8
2016Detailed filing. Detailed filing data is available for this year.$217$99.1$118$272$255$17.0
2015Detailed filing. Detailed filing data is available for this year.$214$117$97.5$282$277$4.19
2014Detailed filing. Detailed filing data is available for this year.$243$145$97.1$310$317$7.10
2013Facts available. Structured filing facts are available, but richer extracted sections are limited.$236$135$101$307
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$223$109$114$292
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$224$104$120$281
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$222$112$109$250
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jul 1, 2024 to Jun 30, 2025
Signed
Feb 26, 2026
Return Version
2024v5.5
Gross Receipts
$606,472,218
Mission and Program Overview

Mission

Our mission is to cure leukemia, lymphoma, hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

Cure leukemia,lymphoma,hodgkin's disease, myeloma; improve quality of life of patients and families.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$354,480,856$330,481,970▼ $23,998,886
Savings and Temporary Cash Investments$143,907,675$96,813,180▼ $47,094,495
Pledges and Grants Receivable$45,469,673$48,116,644▲ $2,646,971
Investments Other Securities$22,812,891$24,669,655▲ $1,856,764
Land, Buildings, and Equipment, Net$10,752,233$9,691,756▼ $1,060,477
Prepaid Expenses and Deferred Charges$5,836,452$9,173,907▲ $3,337,455
Investments Program Related$10,615,299$6,785,419▼ $3,829,880
Cash and Non-Interest-Bearing Accounts$3,858,985$5,202,537▲ $1,343,552
Intangible Assets$316,667$116,667▼ $200,000
Total Assets$602,010,519$532,209,663▼ $69,800,856
Other Assets Total$3,959,788$1,157,928▼ $2,801,860
Liabilities
Grants Payable$155,633,120$122,193,676▼ $33,439,444
Accounts Payable and Accrued Expenses$36,559,192$33,217,287▼ $3,341,905
Deferred Revenue$14,667,950$14,994,156▲ $326,206
Other Liabilities$4,198,076$1,307,601▼ $2,890,475
Total Liabilities$211,058,338$171,712,720▼ $39,345,618
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$251,301,743$204,762,655▼ $46,539,088
Net Assets With Donor Restrictions$139,650,438$155,734,288▲ $16,083,850
Total Net Assets Fund Balance$390,952,181$360,496,943▼ $30,455,238
Total Liabilities and Net Assets / Fund Balance$602,010,519$532,209,663▼ $69,800,856

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$9,691,756$19,862,721$29,554,477

Endowment Activity

PeriodBeginningContrib.Gain/LossOther UsesEnd
2024$8,277,308-▲ $750,040-$8,591,308
2023$7,730,391$80,666▲ $787,363-$8,277,308
2022$7,288,293$30,000▲ $713,739-$7,730,391
2021$7,381,460$1,129,903▼ $913,685-$7,288,293
2020$5,902,791$1,650▲ $1,726,314-$7,381,460
Compensation and Service Providers
Top Officer Pay54th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
E Anders KolbPresident & CEOFT$678,834$251,683$930,517
Gwen NicholsEvp, Chief Med OfficerFT$466,269$315,466$781,735
Gordon MillerEvp, Chief Fin OfficerFT$404,089$300,708$704,797
Flora Coker PowellEvp, Chief Rev OfficerFT$433,238$138,909$572,147
Dale NissenbaumFormer Evp, Gen Cnsl - End 05/2024FT$397,356$166,210$563,566
Lee GreenbergerSVP, Chief Sci Officer - End 12/2024FT$346,235$107,487$453,722
Susan BrownSVP, Chief Sus Off End - 11/12/2024FT$375,110$73,965$449,075
Florence GodfreySVP, Chief Experience OfficerFT$343,837$103,301$447,138
Elisa WeissSVP, EducationFT$323,795$89,327$413,122
Andrew PerrySVP, Bus Ops and TechnologyFT$331,055$75,980$407,035
Meredith FogelEvp, Gen Counsel - Start 09/2024FT$264,771$102,500$367,271
Troy DunmireFormer Evp, Cf Op Off - End 01/2024FT$263,176$8,458$271,634
Shonette Harrison CarewEvp, Chief Admin Off - Start 09/2024FT$112,033$50,599$162,632
Orlando AshworthEvp, Chief People - Start 10/2024FT$95,040$562$95,602

Board Members and Trustees

NameTitle
Alessandra ToccoChair
Freda WangVice Chair
Janice Gabrilove MdAt Large
Alex OkaforBod Member
Ari MelnickBod Member
Jeff SachsBod Member
Jim ReddochBod Member
Kathleen MeriwetherBod Member
LYNNE O'BRIENBod Member
Leroy BallBod Member
Lilian SternBod Member
M Casey CunninghamBod Member
Mark BarrenecheaBod Member
Mike FarmerBod Member
Rayne H Rouce MdBod Member
Renzo CanettaBod Member
Richard BaggerBod Member
Richard RendinaBod Member
Robert RosenBod Member
Ruben MesaBod Member
Sharon CastellinoBod Member
Yvette TremontiBod Member
Marla PerskySecretary/treasurer

Highest Paid Contractors

ContractorServicesLocationCompensation
Icon Plc - Pharmaceutical Research AssocClinical Trial4130 PARKLAKE AVENUE SUITE 400, Raleigh, NC 27612$9,616,721
Patient Advocate FoundationPat Assist Proc421 BUTLER FARM RD, Hampton, VA 23666$6,765,372
Moore A Series LLCProfessional Fundraising4200 PARLIAMENT PLACE SUITE 300, Lanham, MD 20706$4,664,047
SalesforceSoftware140 E 45TH ST, New York, NY 10017$4,565,999
KapadiClinical Trial9650 STRICKLAND ROAD SUITE 103-150, Raleigh, NC 27615$3,123,545
Revenue and Support

Revenue Composition

Contributions and Grants
$315,334,371
Program Service Revenue
$16,079,272
Investment Income
$22,273,771
Other Revenue
$5,011,090
All Other Contributions
$175,722,703
Change in Net Assets
$-39,429,972

Noncash Contribution Practices

Property subject to holding requirements
No
Reviewed unusual noncash gifts
Yes
Third parties used for noncash contributions
No

Noncash Contributions

Contribution TypeContribution CountReported AmountValuation Method
Securities Publicly Traded253$4,246,606Fair Market Value
Other Non Cash Contri Table19$18,490Fair Market Value
Food Inventory3$6,379Fair Market Value
Other Non Cash Contri Table1$2,600Fair Market Value
Total Noncash Contributions276$4,274,075-

Audited Revenue Reconciliation

Revenue per Audited Statements
$358,410,097
Revenue Not Reported on Financial Statements
$288,407
Revenue Not Reported on Form 990
$15,607,867
Total Revenue per Audited Statements
$374,017,964
Total Revenue per Form 990
$358,698,504
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$154,628,780
Grants and Similar Amounts Paid$124,083,834
Other Expenses$110,061,092
Total Fundraising Expense$49,752,524
Professional Fundraising Fees$9,354,770

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$76,835,715$23,453,195$19,290,341$119,579,251
Grants to Domestic Individuals$72,847,874--$72,847,874
Grants to Domestic Orgs$43,522,719--$43,522,719
Fees for Services Other$16,408,138$3,981,350$3,779,723$24,169,211
Other Employee Benefits$11,653,810$4,165,931$2,925,294$18,745,035
Office Expenses$8,563,768$1,398,549$4,098,674$14,060,991
Information Technology$944,969$9,309,320$2,278,452$12,532,741
Travel$8,272,676$1,228,284$1,288,436$10,789,396
Fees for Services Professional Fundraising--$9,354,770$9,354,770
Payroll Taxes$5,607,526$2,004,543$1,407,579$9,019,648
Foreign Grants$7,713,241--$7,713,241
Advertising$4,611,440$991,591$2,002,502$7,605,533
Other Expenses$4,086,879$461,536$668,774$5,217,189
Depreciation Depletion$3,602,255$726,974$796,486$5,125,715
Pension Plan Contributions$2,479,454$886,340$622,383$3,988,177
Fees for Services Lobbying$3,514,398--$3,514,398
Occupancy$2,361,477$432,198$527,285$3,320,960
Current Officers, Directors, Trustees, and Key Employees$1,415,470$1,459,842$403,126$3,278,438
Fees for Services Legal$1,274,217$573,397$276,080$2,123,694
Insurance$81,399$1,028,579-$1,109,978
Fees for Services Accounting-$419,767-$419,767
Fees for Service Investment Mgmnt Fees$221,500$34,288$32,619$288,407
Comp Disqual Persons-$18,231-$18,231
Total Functional Expenses$13,280,340$0$3,885,425$17,165,765

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$416,711,240
Total Expenses per Form 990$398,128,476
Expenses per Audited Statements$397,840,069
Expenses Not Reported on Form 990$18,871,171
Expenses Not Reported on Financial Statements$288,407
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Dana-farber Cancer Institute IncBoston, MA501(c)(3)Research Grant$5,197,687
The University of Texas Md Anderson Cancer CenterHouston, TXGovtResearch Grant$2,518,448
Sloan Kettering Institute for Cancer ResearchNew York, NY501(c)(3)Research Grant$2,513,800
The Board of Trustees of the Leland Stanford Junior UniversityStanford, CA501(c)(3)Research Grant$2,257,440
Washington University in St LouisSt Louis, MOGovtResearch Grant$2,252,023
Joan & Sanford I Weill Medical College of Cornell UniversityNew York, NY501(c)(3)Research Grant$2,115,000
University of FloridaGainesville, FL501(c)(3)Research Grant$2,009,874
University of Colorado Denver Anschutz Medical CampusAurora, CO501(c)(3)Research Grant$1,966,500
Emory UniversityAtlanta, GA501(c)(3)Research Grant$1,661,071
Fred Hutchinson Cancer CenterSeattle, WA501(c)(3)Research Grant$1,550,000
H Lee Moffitt Cancer Center & Research InstituteAtlanta, GA501(c)(3)Research Grant$1,312,498
ST JUDE CHILDREN'S RESEARCH HOSPITALMemphis, TN501(c)(3)Research Grant$1,308,000
University of MiamiAtlanta, GA501(c)(3)Research Grant$1,280,887
New York Columbia University Medical CenterNew York, NY501(c)(3)Research Grant$1,173,600
Massachusetts General HospitalBoston, MA501(c)(3)Research Grant$1,073,600
The Trustees of the University of Pennsylvania Medical CenterPhiladelphia, PAGovtResearch Grant$1,069,925
University of VirginiaCharlottesville, VA501(c)(3)Research Grant$999,997
The Regents of the University of California San FranciscoSan Francisco, CA501(c)(3)Research Grant$945,000
Albert Einstein College of MedicineBronx, NY501(c)(3)Research Grant$943,343
BOSTON CHILDREN'S HOSPITALBoston, MAGovtResearch Grant$750,000
Yale UniversityNew Haven, CT501(c)(3)Research Grant$664,225
Perelman School of Medicine at the University of PennsylvaniaPhiladelphia, PA501(c)(3)Research Grant$640,000
The Research Institute of Fox Chase Cancer CenterPhiladelphia, PA501(c)(3)Research Grant$620,000
Osu FoundationColumbus, OHGovtResearch Grant$579,132
Indiana UniversityFort Wayne, IN501(c)(3)Research Grant$504,297
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTERCincinatti, OH501(c)(3)Research Grant$500,541
Auron TherapeuticsNewton, MA501(c)(3)Therapy Acceleration$500,000
Durham Va Medical CenterDurham, NC501(c)(3)Research Grant$500,000
Houston Methodist Research InstituteHouston, TX501(c)(3)Research Grant$500,000
Solu TherapeuticsBoston, MA501(c)(3)Therapy Acceleration$499,999
Vanderbilt University Medical CenterDallas, TXGovtResearch Grant$424,913
Beckman Research Institute of the City of HopeDuarte, CAGovtResearch Grant$375,000
The Medical College of WisconsinMilwaukee, WIGovtResearch Grant$375,000
Baylor College of MedicineDallas, TX501(c)(3)Research Grant$370,000
The Regents of the University of California San DiegoLa Jolla, CA501(c)(3)Research Grant$370,000
The Ohio State UniversityColumbus, OH501(c)(3)Research Grant$296,867
THE CHILDREN'S HOSPITAL OF PHILADELPHIAPhiladelphia, PA501(c)(3)Research Grant$284,000
Icahn School of Medicine at Mount SinaiNew York, NY501(c)(3)Research Grant$253,000
George Washington UniversityWashington, DC501(c)(3)Research Grant$250,000
Texas A&m University Health Science CenterBryan, TXGovtResearch Grant$250,000
The Feinstein Institutes for Medical ResearchManhasset, NYGovtResearch Grant$250,000
The University of Texas at AustinAustin, TXGovtResearch Grant$250,000
University of Arkansas for Medical SciencesLittle Rock, AR501(c)(3)Research Grant$250,000
University of California at DavisDavis, CA501(c)(3)Research Grant$250,000
SEATTLE CHILDREN'S HOSPITALSeattle, WAGovtResearch Grant$249,999
Nyu Grossman School of MedicineNew York, NYGovtResearch Grant$245,940
University of Southern CaliforniaLos Angeles, CA501(c)(3)Research Grant$239,560
Duke University Medical CenterCharlotte, NC501(c)(3)Research Grant$194,691
Oregon Health & Science University Cancer InstitutePortland, ORGovtResearch Grant$190,000
Northwestern UniversityEvanston, IL501(c)(3)Research Grant$157,406
The Jackson LaboratoryBar Harbor, ME501(c)(3)Research Grant$155,000
The Brigham and Womens Hospital IncBoston, MAGovtResearch Grant$150,000
Atrium Health FoundationCharlotte, NCGovtResearch Grant$125,110
Mayo Clinic RochesterMinneapolis, MN-Research Grant$125,000
Rhode Island HospitalProvidence, RI501(c)(3)Research Grant$125,000
The University of Alabama at BirminghamBirmingham, AL501(c)(3)Research Grant$125,000
The University of ChicagoChicago, IL501(c)(3)Research Grant$123,600
Maine Medical CenterPortland, ME501(c)(3)Research Grant$120,000
Rutgers UniversityNew Brunswick, NJ501(c)(3)Research Grant$120,000
University of PittsburghPittsburgh, PAGovtResearch Grant$120,000
Van Andel Research InstituteGrand Rapids, MI501(c)(3)Research Grant$120,000
University of Pennsylvania Department of MedicinePhiladelphia, PAGovtResearch Grant$104,214
University of Wisconsin at MadisonMadison, WI501(c)(3)Research Grant$73,600
The Regents of the University of California Los AngelesLos Angeles, CAGovtResearch Grant$70,000
Unc Lineberger Comprehensive Cancer CenterChapel Hill, NC501(c)(3)Research Grant$70,000
Veterans Health FoundationPittsburgh, PA-Research Grant$50,000
Versiti Blood Center of WisconsinMilwaukee, WIGovtResearch Grant$37,500

International Summary

Offices
1
Employees
0
Spending
$29,364,397

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
Yes
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
Yes
Transfers to foreign corporations
Yes

International Activities

RegionActivityServicesOfficesEmployeesSpending
Central America & CaribbeanInvestmentsInvestments--$15,082,741
EuropeInvestmentsInvestments--$6,568,415
EuropeResearch FundingResearch Grants--$5,115,956
East Asia & the PacificResearch FundingResearch Grants--$1,518,725
North AmericaResearch FundingResearch Grants1-$1,078,560
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
Yes

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$22,529,133
Fundraising Gross Income$16,736,434
Professional Fundraising Fees$9,354,770

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Lake Tahoe Cycle$3,086,769$529,632$194,052$335,580
Manhattan Walk$2,925,993$273,106$14,747$258,359
Total Events$155,992,116$16,736,434$22,529,133$-5,792,699
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
Sheena MehtaDaughter-in-law of Board Member of Janice GabriloveCompensationNo$18,231
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Capital Lease Liability$1,307,601
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
Yes
Business relationship with organization members
No
Material changes to governing documents
Yes
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 4

“All of blood cancer uniteds bylaws and charters were changed from leukemia and lymphoma society to blood cancer united as part of an organization-wide name change. No other changes were made.”

Form 990, Part VI, Section B, Line 11B

“The form 990 was prepared by the blood cancer united's finance department and was reviewed by the cfo, senior vice president of finance, vice president, controller, and kpmg for comment and suggested revisions. The form 990 was then provided to the audit committee, which is a committee of the board of directors. The audit committee reviewed the 990 and provided input prior to filing. The final draft form 990, as will be filed with the irs, was provided to the entire board of directors prior to filing with the irs.”

Form 990, Part VI, Section B, Line 12C

“All blood cancer united key persons are required to complete annual conflict of interest disclosure statements. Other lls representatives are encouraged to disclose potential conflicts and may be required to complete disclosure statements when requested. All disclosure statements are reviewed by the legal department and escalated to the audit committee for evaluation and management of actual or potential conflicts of interest.”

Form 990, Part VI, Section B, Line 15

“The talent and compensation committee, comprised of independent board members, establishes compensation guidelines and recommends ceo compensation to the executive committee based on performance evaluations and market studies. The executive committee establishes ceo performance goals and conducts evaluations. The executive committee makes final recommendations to the board for approval, with all decisions documented in committee minutes. The last evaluation was november 2024.”

Form 990, Part VI, Section C, Line 19

“Blood cancer united makes its annual financial statements available to the public on its website at bloodcancerunited.org. Its governing documents are made available upon request for public inspection. Any identified conflicts of interest are disclosed in the 990.”

Filing and Contact Details

Filer

Filer Name
Blood Cancer United Inc
EIN
13-5644916
Phone
9149495213
Address
1201 15TH STREET NW SUITE 410, WASHINGTON, DC 20005

Signing Officer

Name
Gordon Miller Jr
Title
Chief Financial Officer
Phone
9149495213
Signed
2026-02-26
Discuss with paid preparer
Yes

Organization Details

Principal Officer
E Anders Kolb Md
Formed
1949
Legal Domicile
Ny
Voting Board Members
23
Independent Board Members
19
Employees
1,390
Volunteers
300,000

Preparer

Firm
Kpmg Llp
Address
345 PARK AVENUE, NEW YORK, NY 10154-0102
Preparer
Devin L Duncan
Phone
2127589700
Supplemental Narrative

Additional Explanations

FORM 990, PART XI, LINE 9:

“Foreign currency adjustments -478,749.”

Financial Statement Notes

PART III, LINE 1A:

“The blood cancer united collection is of photographs which are used for public exhibition at fundraising events held to support blood cancer united's programs.”

PART IV, LINE 1B:

“Blood cancer united held approximately $1 million in escrow on behalf of ifli as part of a pass-through grant agreement.”

PART V, LINE 4:

“Blood cancer united's endowments are intended to fund research as well as support blood cancer united's public education programs.”

PART X, LINE 2:

“Blood cancer united, blood cancer united research programs, inc., and blood cancer united research foundation qualify as charitable organizations as defined by internal revenue code section 501(c)(3) and, accordingly, are exempt from federal income taxes under internal revenue code section 501(a). Blood cancer united's limited liability companies are disregarded pass-through entities and are exempt from federal income taxes under internal revenue code section 501(a). Additionally, since these organizations are publicly supported, contributions qualify for the maximum charitable contribution deduction under the internal revenue code. Llsc is registered as a charitable organization under the income tax act (canada) and is, therefore, not subject to income taxes if certain disbursement requirements are met. Blood cancer united and its related entities recognize the effect of tax positions only if those positions are more likely than not to be sustained. Income generated from activities unrelated to blood cancer united's exempt purpose is subject to tax under internal revenue code section 511. There were no entities that recognized unrelated business income tax liability for the years ended june 30, 2024 and june 30, 2025.”

PART XI, LINE 2D - OTHER ADJUSTMENTS:

“Lls canada revenue 11,026,150.”

PART XII, LINE 2D - OTHER ADJUSTMENTS:

“Lls canada expense 11,240,168.”

Raw XML AppendixShowing 400 of 2,392 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt036559192
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt033217287
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0CURE LEUKEMIA,LYMPHOMA,HODGKIN'S DISEASE, MYELOMA; IMPROVE QUALITY OF LIFE OF PATIENTS AND FAMILIES.
IRS990/AdvertisingGrp/FundraisingAmt02002502
IRS990/AdvertisingGrp/ManagementAndGeneralAmt0991591
IRS990/AdvertisingGrp/ProgramServicesAmt04611440
IRS990/AdvertisingGrp/TotalAmt07605533
IRS990/AllOtherContributionsAmt0175722703
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0GORDON MILLER JR
IRS990/BooksInCareOfDetail/PhoneNum09148218935
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt01201 15TH STREET NW SUITE 410
IRS990/BooksInCareOfDetail/USAddress/CityNm0WASHINGTON
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0DC
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020005
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd01
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt03858985
IRS990/CashNonInterestBearingGrp/EOYAmt05202537
IRS990/ChangeToOrgDocumentsInd01
IRS990/CntrctRcvdGreaterThan100KCnt0175
IRS990/CollectionsOfArtInd01
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt0403126
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt01459842
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt01415470
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt03278438
IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt018231
IRS990/CompDisqualPersonsGrp/TotalAmt018231
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt09616721
IRS990/ContractorCompensationGrp/CompensationAmt16765372
IRS990/ContractorCompensationGrp/CompensationAmt24664047
IRS990/ContractorCompensationGrp/CompensationAmt34565999
IRS990/ContractorCompensationGrp/CompensationAmt43123545
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt04130 PARKLAKE AVENUE SUITE 400
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt1421 BUTLER FARM RD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt24200 PARLIAMENT PLACE SUITE 300
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt3140 E 45TH ST
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt49650 STRICKLAND ROAD SUITE 103-150
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0RALEIGH
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1HAMPTON
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm2LANHAM
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm3NEW YORK
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm4RALEIGH
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0NC
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1VA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd2MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd3NY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd4NC
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd027612
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd123666
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd220706
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd310017
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd427615
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0ICON PLC - PHARMACEUTICAL RESEARCH ASSOC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1PATIENT ADVOCATE FOUNDATION
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt2MOORE A SERIES LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt3SALESFORCE
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt4KAPADI
IRS990/ContractorCompensationGrp/ServicesDesc0CLINICAL TRIAL
IRS990/ContractorCompensationGrp/ServicesDesc1PAT ASSIST PROC
IRS990/ContractorCompensationGrp/ServicesDesc2PROFESSIONAL FUNDRAISING
IRS990/ContractorCompensationGrp/ServicesDesc3SOFTWARE
IRS990/ContractorCompensationGrp/ServicesDesc4CLINICAL TRIAL
IRS990/ContriRptFundraisingEventAmt0139255682
IRS990/CreditCounselingInd01
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0315334371
IRS990/CYGrantsAndSimilarPaidAmt0124083834
IRS990/CYInvestmentIncomeAmt022273771
IRS990/CYOtherExpensesAmt0110061092
IRS990/CYOtherRevenueAmt05011090
IRS990/CYProgramServiceRevenueAmt016079272
IRS990/CYRevenuesLessExpensesAmt0-39429972
IRS990/CYSalariesCompEmpBnftPaidAmt0154628780
IRS990/CYTotalExpensesAmt0398128476
IRS990/CYTotalFundraisingExpenseAmt049752524
IRS990/CYTotalProfFndrsngExpnsAmt09354770
IRS990/CYTotalRevenueAmt0358698504
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd01
IRS990/DeferredRevenueGrp/BOYAmt014667950
IRS990/DeferredRevenueGrp/EOYAmt014994156
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt0796486
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0726974
IRS990/DepreciationDepletionGrp/ProgramServicesAmt03602255
IRS990/DepreciationDepletionGrp/TotalAmt05125715
IRS990/Desc0A) RESEARCH PROGRAMS:AT BLOOD CANCER UNITED, WE ARE PUSHING BOUNDARIES TOWARD POWERFUL NEW THERAPIES. WE PROPEL GROUNDBREAKING CANCER TREATMENTS THROUGH ALL PHASES OF THE RESEARCH AND DRUG DEVELOPMENT PROCESS AND ARE PROUD THAT OUR SUPPORT HAS BEEN KEY TO ADVANCING 80% OF THE 153 BLOOD CANCER TREATMENT APPROVALS SINCE 2017.AS WE CONTINUED TO SUPPORT THE SEARCH FOR LIFESAVING AND LESS TOXIC TREATMENTS IN 2025, WE INVESTED IN EXCITING RESEARCH FRONTIERS, INCLUDING PRECISION MEDICINE, IMMUNOTHERAPY, AND LINKS BETWEEN MUTATIONS AND BLOOD CANCER-ADVANCEMENTS THAT ARE CHANGING THE PARADIGM OF CANCER TREATMENT. IN THE PROCESS, WE PROPELLED SEVERAL NOVEL SCIENCE INITIATIVES TO NEW HEIGHTS-MANY OF WHICH HARDLY SEEMED POSSIBLE JUST A SHORT TIME AGO.WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, BLOOD CANCER UNITED FUNDED EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVE OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS, AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. BLOOD CANCER UNITED IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS AS SOON AS POSSIBLE. IN ADDITION, WHILE BLOOD CANCER UNITED DEDICATES SUBSTANTIAL FUNDING TO ADVANCING NOVEL TREATMENTS FOR BLOOD CANCER, WE RECOGNIZE THAT IT IS EQUALLY IMPORTANT THAT WE COMMIT TO IMPROVING PATIENT ACCESS TO THESE ESSENTIAL THERAPIES. TO THIS END, BLOOD CANCER UNITED ALSO SUPPORTS HEALTH SERVICES RESEARCH WORKING TO IDENTIFY BARRIERS THAT PREVENT CERTAIN PATIENTS FROM BEING ABLE TO ACCESS THE TREATMENT AND CARE THAT THEY NEED AND FINDING ACTIONABLE SOLUTIONS THAT BLOOD CANCER UNITED CAN IMPLEMENT TO OVERCOME THESE BARRIERS AND ADVANCE ITS MISSION. TO DATE, BLOOD CANCER UNITED HAS INVESTED OVER $2 BILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. OUR SUSTAINED RESEARCH INVESTMENT OVER MULTIPLE DECADES HAS PAID OFF HANDSOMELY. THIS IS BEST DEMONSTRATED BY OUR SEMINAL INVESTMENT IN CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR T) THERAPY STARTING IN 1990 THAT, SINCE 2017, HAS TRANSLATED INTO 18 FDA-APPROVALS FOR PEDIATRIC AND ADULT B-CELL ACUTE LEUKEMIA, FOR SEVERAL TYPES OF NON-HODGKIN LYMPHOMA, AND MULTIPLE MYELOMA. CAR T-CELL THERAPY HAS IN SOME CASES PRODUCED CURES IN PATIENTS WHO HAVE FAILED ALL OTHER THERAPEUTIC OPTIONS.IN FISCAL YEAR 2025, BLOOD CANCER UNITED SUPPORTED RESEARCH IN THE U.S., CANADA AND SEVERAL OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF APPROXIMATELY $81.3 MILLION. RESEARCH FUNDING WAS DISTRIBUTED ACROSS ALL BLOOD CANCERS.EQUITY IN ACCESS RESEARCH PROGRAM IN FISCAL YEAR 2022, BLOOD CANCER UNITED LAUNCHED THE EQUITY IN ACCESS RESEARCH PROGRAM, WHICH AIMS TO FUND HEALTH SERVICES RESEARCH THAT WILL GENERATE ACTIONABLE EVIDENCE TO ASSIST BLOOD CANCER UNITED IN ADVOCATING FOR CHANGES IN HEALTHCARE POLICY, DEVELOPING PATIENT-FACING PROGRAMS, AND FOSTERING PRACTICE CHANGE TO EXTEND AND IMPROVE THE LIVES OF ALL BLOOD CANCER PATIENTS. EQUITY IN ACCESS HAS AWARDED NEARLY $18 MILLION TO RESEARCHERS ADDRESSING CRITICAL ISSUES SUCH AS THE COST OF ORAL ANTICANCER MEDICATIONS, THE ROLE OF HEALTH INSURANCE IN FINANCIAL HARDSHIP, AND ACCESS FOR EVERY PATIENT TO CLINICAL TRIALS. BLOOD CANCER UNITED RECOGNIZES THE CRITICAL NEED FOR HIGH-QUALITY EVIDENCE ON INTERVENTIONS TO INCREASE PARTICIPATION IN THERAPEUTIC CANCER CLINICAL TRIALS, WHICH ARE CONSIDERED HIGH-QUALITY CANCER CARE, PARTICULARLY AMONG UNDERREPRESENTED GROUPS (E.G., PEOPLE WHO HAVE LOW INCOMES, PEOPLE WHO LIVE IN RURAL AREAS, ETHNICALLY AND RACIALLY MINORITIZED GROUPS). IN FISCAL YEAR 2025 ALONE, EQUITY IN ACCESS AWARDED NEARLY $5 MILLION TO RESEARCHERS WHO WILL IMPLEMENT AND EVALUATE NOVEL INTERVENTION APPROACHES DESIGNED TO INCREASE THERAPEUTIC CLINICAL TRIAL ENROLLMENT. THERAPY ACCELERATION PROGRAM (TAP)TAP IS BLOOD CANCER UNITED'S MISSION-DRIVEN, STRATEGIC VENTURE PHILANTHROPY INITIATIVE THAT SEEKS TO ACCELE
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd01
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0139650438
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt0155734288
IRS990/DonorRstrOrQuasiEndowmentsInd01
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt01390
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0127080673
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FederatedCampaignsAmt0355986
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0419767
IRS990/FeesForServicesAccountingGrp/TotalAmt0419767
IRS990/FeesForServicesLegalGrp/FundraisingAmt0276080
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0573397
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt01274217
IRS990/FeesForServicesLegalGrp/TotalAmt02123694
IRS990/FeesForServicesLobbyingGrp/ProgramServicesAmt03514398
IRS990/FeesForServicesLobbyingGrp/TotalAmt03514398
IRS990/FeesForServicesOtherGrp/FundraisingAmt03779723
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt03981350
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt016408138
IRS990/FeesForServicesOtherGrp/TotalAmt024169211
IRS990/FeesForServicesProfFundraising/FundraisingAmt09354770
IRS990/FeesForServicesProfFundraising/TotalAmt09354770
IRS990/FeesForSrvcInvstMgmntFeesGrp/FundraisingAmt032619
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt034288
IRS990/FeesForSrvcInvstMgmntFeesGrp/ProgramServicesAmt0221500
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0288407
IRS990/ForeignActivitiesInd01
IRS990/ForeignCountryCd0CA
IRS990/ForeignCountryCd1PL
IRS990/ForeignFinancialAccountInd01
IRS990/ForeignGrantsGrp/ProgramServicesAmt07713241
IRS990/ForeignGrantsGrp/TotalAmt07713241
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt30.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt40.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt50.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt60.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt70.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt80.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt90.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt100.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt110.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt120.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt130.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt150.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt160.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt170.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt180.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt190.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt200.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt210.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt220.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt230.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt250.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt260.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt270.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt280.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt290.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt300.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt310.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt320.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt330.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt350.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt360.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt04.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt14.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt24.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt34.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt44.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt54.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt64.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt74.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt84.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt94.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt104.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt114.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt124.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt134.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt144.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt154.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt164.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt174.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt184.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt194.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt204.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt214.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt224.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2540.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt3040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt3140.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt3240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt3340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt3440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt3540.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt3640.00
IRS990/Form990PartVIISectionAGrp/FormerOfcrDirectorTrusteeInd0X
IRS990/Form990PartVIISectionAGrp/FormerOfcrDirectorTrusteeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd13X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd14X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd15X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd16X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd17X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd18X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd19X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd20X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd21X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd22X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd5X
IRS990/Form990PartVIISectionAGrp/OfficerInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd7X
IRS990/Form990PartVIISectionAGrp/OfficerInd8X
IRS990/Form990PartVIISectionAGrp/OfficerInd9X
IRS990/Form990PartVIISectionAGrp/OfficerInd10X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt160
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt170
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt180
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt190
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt200
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt210
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt220
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2350519
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2445341
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2556317
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2659334
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2754903
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt28367
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt29562
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt3045162
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt3127278
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt3240820
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt3345294
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt3415358
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt3515807
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt368453
IRS990/Form990PartVIISectionAGrp/PersonNm0ALESSANDRA TOCCO
IRS990/Form990PartVIISectionAGrp/PersonNm1FREDA WANG
IRS990/Form990PartVIISectionAGrp/PersonNm2MARLA PERSKY
IRS990/Form990PartVIISectionAGrp/PersonNm3JANICE GABRILOVE MD
IRS990/Form990PartVIISectionAGrp/PersonNm4LEROY BALL
IRS990/Form990PartVIISectionAGrp/PersonNm5RICHARD BAGGER
IRS990/Form990PartVIISectionAGrp/PersonNm6MARK BARRENECHEA
IRS990/Form990PartVIISectionAGrp/PersonNm7RENZO CANETTA
IRS990/Form990PartVIISectionAGrp/PersonNm8M CASEY CUNNINGHAM
IRS990/Form990PartVIISectionAGrp/PersonNm9SHARON CASTELLINO
IRS990/Form990PartVIISectionAGrp/PersonNm10MIKE FARMER
IRS990/Form990PartVIISectionAGrp/PersonNm11ARI MELNICK
IRS990/Form990PartVIISectionAGrp/PersonNm12KATHLEEN MERIWETHER
IRS990/Form990PartVIISectionAGrp/PersonNm13RUBEN MESA
IRS990/Form990PartVIISectionAGrp/PersonNm14LYNNE O'BRIEN
IRS990/Form990PartVIISectionAGrp/PersonNm15ALEX OKAFOR
IRS990/Form990PartVIISectionAGrp/PersonNm16JIM REDDOCH
IRS990/Form990PartVIISectionAGrp/PersonNm17RICHARD RENDINA
IRS990/Form990PartVIISectionAGrp/PersonNm18ROBERT ROSEN
IRS990/Form990PartVIISectionAGrp/PersonNm19RAYNE H ROUCE MD
IRS990/Form990PartVIISectionAGrp/PersonNm20JEFF SACHS
IRS990/Form990PartVIISectionAGrp/PersonNm21LILIAN STERN
IRS990/Form990PartVIISectionAGrp/PersonNm22YVETTE TREMONTI
IRS990/Form990PartVIISectionAGrp/PersonNm23E ANDERS KOLB
IRS990/Form990PartVIISectionAGrp/PersonNm24GWEN NICHOLS
IRS990/Form990PartVIISectionAGrp/PersonNm25GORDON MILLER
IRS990/Form990PartVIISectionAGrp/PersonNm26FLORA COKER POWELL
IRS990/Form990PartVIISectionAGrp/PersonNm27MEREDITH FOGEL
IRS990/Form990PartVIISectionAGrp/PersonNm28SHONETTE HARRISON CAREW
IRS990/Form990PartVIISectionAGrp/PersonNm29ORLANDO ASHWORTH
IRS990/Form990PartVIISectionAGrp/PersonNm30LEE GREENBERGER
IRS990/Form990PartVIISectionAGrp/PersonNm31SUSAN BROWN
IRS990/Form990PartVIISectionAGrp/PersonNm32FLORENCE GODFREY
IRS990/Form990PartVIISectionAGrp/PersonNm33ELISA WEISS
IRS990/Form990PartVIISectionAGrp/PersonNm34ANDREW PERRY
IRS990/Form990PartVIISectionAGrp/PersonNm35DALE NISSENBAUM
IRS990/Form990PartVIISectionAGrp/PersonNm36TROY DUNMIRE
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt200
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt210
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt220
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt23879998
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt24736394
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt25648480
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt26512813
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt27312368
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt28162265
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt2995040
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30408560
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt31421797
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt32406318
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt33367828
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt34391677
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt35547759
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt36263181
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt200
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt210
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt220
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt230
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt240
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt250
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt260
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt270
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt280
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt290
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt300
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt310
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt320

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • $250M-$1B nonprofits